Hybrid Imaging During Transcatheter Structural Heart Interventions

被引：40

作者：

Biaggi P. ^{[1
]}

Fernandez-Golfín C. ^{[2
]}

Hahn R. ^{[3
]}

Corti R. ^{[1
]}

机构：

[1] Heart Clinic Zurich, Witellikerstrasse 40, Zurich

[2] Ramón y Cajal University Hospital, Carretera de Colmenar Km 9.400, Madrid

[3] Columbia University Medical Center, 177 Fort Washington Avenue, New York, 10032, NY

来源：

Current Cardiovascular Imaging Reports | 2015年 / 8卷 / 9期

关键词：

Echocardiography; computed tomography; cardiac magnetic resonance imaging; EchoNavigator; DynaCT; Fluoroscopy; Fusion imaging; Heart team; Interventions; MitraClip; left atrial appendage; Mitral valve; aortic valve; paravalvular leak; Multimodality image integration; Percutaneous; Structural heart disease; TAVR; X-ray;

D O I：

10.1007/s12410-015-9349-6

中图分类号：

学科分类号：

摘要：

Fusion of different imaging modalities has gained increasing popularity over the last decade. However, most fusions are done between static rather than dynamic images. In order to adequately visualize the complex three-dimensional structures of the beating heart, high-temporal and spatial image resolutions are mandatory. Currently, only the combination of transesophageal echocardiography with fluoroscopy allows real-time image fusion of high quality during structural heart disease (SHD) interventions. The use of markers as well as real-time image overlay greatly facilitates communication between SHD team members and potentially increases procedural success while reducing radiation dose and use of contrast. However, to date there is only limited evidence that fusion imaging improves safety and outcomes of SHD interventions. This review highlights the benefits of fusion imaging during SHD interventions such as transseptal puncture and closure of atrial septal defects and left atrial appendage as well as interventions on the mitral and aortic valve. © 2015, The Author(s).

引用

页数：14

共 43 条

[1]

Nkomo V.T., Gardin J.M., Skelton T.N., Gottdiener J.S., Scott C.G., Enriquez-Sarano M., Burden of valvular heart diseases: a population-based study, Lancet, 368, pp. 1005-1011, (2006)

[2]

Nashef S.A., Roques F., Sharples L.D., Et al., EuroSCORE II, Eur J Cardiothorac Surg, 41, pp. 734-744, (2012)

[3]

Smith C.R., Leon M.B., Mack M.J., Et al., Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, pp. 2187-2198, (2011)

[4]

Adams D.H., Popma J.J., Reardon M.J., Et al., Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 370, pp. 1790-1798, (2014)

[5]

Reddy V.Y., Sievert H., Halperin J., Et al., Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial, JAMA, 312, pp. 1988-1998, (2014)

[6]

Maisano F., Franzen O., Baldus S., Et al., Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe, J Am Coll Cardiol, 62, pp. 1052-1061, (2013)

[7]

Mauri L., Foster E., Glower D.D., Et al., 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation, J Am Coll Cardiol, 62, pp. 317-328, (2013)

[8]

Cheung A., Webb J., Verheye S., Et al., Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation, J Am Coll Cardiol, 64, pp. 1814-1819, (2014)

[9]

Maisano F., Vanermen H., Seeburger J., Et al., Direct access transcatheter mitral annuloplasty with a sutureless and adjustable device: preclinical experience, Eur J Cardiothorac Surg, 42, pp. 524-529, (2012)

[10]

Carminati M., Agnifili M., Arcidiacono C., Et al., Role of imaging in interventions on structural heart disease, Expert Rev Cardiovasc Ther, 11, pp. 1659-1676, (2013)

← 1 2 3 4 5 →